References
- Emmer PM, et al. DC activated by LPS after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006; 81(10)1451–1459
- Rosen A, Casciola-Rosen L. Autoantigens as substrates for apo proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6(1)6–12
- Munoz LE, et al. Apoptosis in the pathogenesis of SLE. Lupus 2008; 17(5)371–375
- Gaipl US, et al. Impaired clearance of dying cells in SLE. Autoimmun Rev 2005; 4(4)189–194
- Banchereau J, Steinman RM. DC and the control of immunity. Nature 1998; 392(6673)245–252
- Xu W, et al. IL-10-producing macrophages preferentially clear early apo cells. Blood 2006; 107(12)4930–4937
- Ip WK, Lau YL. Distinct maturation of, but not migration between, human mdDC upon ingestion of apo cells of early or late phases. J Immunol 2004; 173(1)189–196
- Dieker JW, et al. Apo-induced acetylation of histones is pathogenic in SLE. Arthritis Rheum 2007; 56(6)1921–1933
- Frisoni L, et al. Nuclear autoantigen translocation and autoantibody opsonization lead to increased DC phagocytosis and presentation of nuclear antigens: A novel pathogenic pathway for autoimmunity?. J Immunol 2005; 175(4)2692–2701
- Savill J, et al. A blast from the past: Clearance of apo cells regulates immune responses. Nat Rev Immunol 2002; 2(12)965–975